AI Apps
Transforming cancer diagnosis and treatment with cutting-edge AI and Computational Pathology
At Tribun Health, we develop advanced computational pathology solutions to help clinicians and researchers in cancer diagnosis and prognosis. By pushing the limits of technology, we've developed solutions that have the potential to radically transform the way cancer is diagnosed and treated.
Our technology stack is state-of-the-art, leveraging the power of Convolutional Neural Network-powered Computer Vision. But what really sets us a part is the unique way we address significant challenges, such as digital image quality variability, insufficient data and regulatory constraints that restrict data transfer.
The power of automated analysis
Accelerate and enhance workflow and confidence
Automated tissue detection, segmentation and classification.
Leading the way in AI-enabled pathology innovation
Tribun Health is committed to advancing the field of digital pathology through the development of a comprehensive AI portfolio. CaloPix 5 is built to seamlessly run a range of AI Apps to assist cancer diagnosis and prognosis.Today, our in-house algorithms, and those of key leading AI partners, make our computational pathology platform very powerful and comprehensive:
1. Some of our algorithms are designed to optimize workflow and increase efficiency.
2. Others are focused on providing diagnostic support, enabling pathologists to achieve more efficient, accurate and timely diagnoses.
3. Tribun Health also offers AI algorithms benefiting the drug discovery community.
Below is a list of AI Algorithms offered by Tribun Health, as well as those currently undergoing validation.
Watch Saima Ben Hadj, AI & Computer Vision Director at Tribun Health, discuss the latest AI innovation for cancer diagnosis and treatment. This session took place at the AI for Health Summit '22.
AI solutions for Workflow Optimization
Intelligent slide auto-import that identifies low quality slides (i.e. missing tissue, blur, artefact, out of focus, folds etc)
Eliminate the need for physical staining and avoid delays
Standardize staining and enable running third party AI algorithms on HES slides
Determine appropriate samples for DNA extraction by assessing the availability of sufficient tumor
AI solutions for Diagnostic Support
BREAST
KI67, ER, and PR biomarkers to support therapy decision
BREAST
HER2 scoring to support therapy decision
BREAST
Mitosis detection for patient prognosis
BREAST
KI67 biomarker scoring to support therapy decision
BREAST
Prediction of relapse in early stage ER+ and HER2- breast cancer.
COLON
Colon lesion prescreening to speed up the diagnosis and increase the pathologist confidence
COLON
Detects microsatellite instability (MSI) to better target genomics.
CERVIX
Detect atypical cytology cells for detecting precancerous cases
CERVIC
Detecting cervical lesion to support diagnosis
PROSTATE
Prostate cancer Gleason grading
Stay connected for the latest!
AI solutions for Drug Discovery
PAN-CANCER
Predict patient outcomes and enable discovering new biomarker for enhanced patient stratification.
LIVER
Quantifying Non-alcoholic steatohepatitis features to measure the severity of liver disease.
ANY ORGAN
Analyzing the spatial distribution of the immune cell subtypes and tumoral cells.
Contact us for specific requests!
Disclaimer: Please note that products marked with an (*) are currently in development and are not yet available for purchase. The information provided on this website is subject to change and may not be final. We make no guarantees regarding the accuracy or completeness of the information provided, and we assume no liability for any errors or omissions. By accessing this website, you acknowledge that the products marked with (*) are not yet available and that any information provided is for informational purposes only.
Forging Strategic Partnerships to Drive AI Innovation
Results are worth 1,000 words.
Tribun Health has been competing in a range of algorithm performance contests and is proud to have ranked high in several of them. Namely...